Skip to main content
logo
Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.90
-0.02 (-0.29%)
Jul 31, 2026, 4:08 PM HKT

HKG:3613 Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
397.22500.28540.39645.88607.84
Depreciation & Amortization
92.5585.9880.4573.669.02
Other Amortization
5.812.142.061.870.96
Loss (Gain) From Sale of Assets
-0.85-2.410.38-0.030.44
Asset Writedown & Restructuring Costs
---0.05-
Loss (Gain) From Sale of Investments
4.89--2.88--
Loss (Gain) on Equity Investments
8.73-2.063.261.54-0.26
Provision & Write-off of Bad Debts
61.591.9521.196.487.52
Other Operating Activities
-9.95-28.78-149.7144.9731.62
Change in Accounts Receivable
58.98-116.75492.15-434.1623.19
Change in Inventory
249.72-584.26-543.6-4764.96
Change in Accounts Payable
-39.15-73.3517.12154.24-28.1
Operating Cash Flow
829.52-217.25460.83547.44777.17
Operating Cash Flow Growth
---15.82%-29.56%569.66%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-41.18-43.17-21.87-38.51-23.43
Sale of Property, Plant & Equipment
0.0800.060.130.02
Cash Acquisitions
----3.26-13.55
Investment in Securities
-4.71,332-1,126362.27-234
Other Investing Activities
44.3765.8169.1714.795.22
Investing Cash Flow
-1.431,355-1,079335.41-265.73

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----0.39
Long-Term Debt Repaid
-68.15-63.97-58.73-56.48-50.66
Net Debt Issued (Repaid)
-68.15-63.97-58.73-56.48-50.28
Common Dividends Paid
-292.99-276.24-276.24-234.39-200.9
Other Financing Activities
-17.51-15.09-37.21-35.28-27.47
Financing Cash Flow
-378.64-355.3-372.18-535.42-278.65

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
5.32-9.04-1.28-16.781.48
Net Cash Flow
454.77773.26-991.15330.66234.26

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
788.34-260.42438.97508.94753.74
Free Cash Flow Growth
---13.75%-32.48%630.55%
Free Cash Flow Margin
52.09%-16.16%28.79%29.40%48.44%
Free Cash Flow Per Share
0.94-0.310.520.610.90
Levered Free Cash Flow
686.19-382.46318.64315.94593.34
Unlevered Free Cash Flow
689.73-378.41322.38318.85596.28

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.666.485.984.664.71
Cash Income Tax Paid
77.13108.42231.0419.16137.84
Change in Working Capital
269.55-774.35-34.32-326.9160.04